Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

January 2017; Volume 37,Issue 1

Reviews

  • You have access
    Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review
    AUSTIN HUY NGUYEN, SHANNON Q. DETTY and DEVENDRA K. AGRAWAL
    Anticancer Research January 2017, 37 (1) 1-7;
  • You have access
    Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes
    DEMETRIOS MORIS, DIMITRIOS DIMITROULIS, SPIRIDON VERNADAKIS, ALEXANDROS PAPALAMPROS, ELEFTHERIOS SPARTALIS, ATHANASIOS PETROU, TIMOTHY M. PAWLIK and EVANGELOS FELEKOURAS
    Anticancer Research January 2017, 37 (1) 9-14;
  • You have access
    Three Pathways of Colonic Carcinogenesis in Rats
    CARLOS A. RUBIO
    Anticancer Research January 2017, 37 (1) 15-20;
  • You have access
    Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
    JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA
    Anticancer Research January 2017, 37 (1) 21-33;
  • You have access
    Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
    CHRISTOS DAMASKOS, SERENA VALSAMI, MICHAEL KONTOS, ELEFTHERIOS SPARTALIS, THEODOROS KALAMPOKAS, EMMANOUIL KALAMPOKAS, ANTONIOS ATHANASIOU, DEMETRIOS MORIS, AFRODITE DASKALOPOULOU, SPYRIDON DAVAKIS, GERASIMOS TSOUROUFLIS, KONSTANTINOS KONTZOGLOU, DESPINA PERREA, NIKOLAOS NIKITEAS and DIMITRIOS DIMITROULIS
    Anticancer Research January 2017, 37 (1) 35-46;

Experimental Studies

  • You have access
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells
    TAKEHARU IMAI, NAOHIDE OUE, KAZUHIRO SENTANI, NAOYA SAKAMOTO, NAOHIRO URAOKA, HIROYUKI EGI, TAKAO HINOI, HIDEKI OHDAN, KAZUHIRO YOSHIDA and WATARU YASUI
    Anticancer Research January 2017, 37 (1) 47-55;
  • You have access
    Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models
    SHUYA YANO, KIYOTO TAKEHARA, HIROYUKI KISHIMOTO, HIROSHI TAZAWA, YASUO URATA, SHUNSUKE KAGAWA, TOSHIYOSHI FUJIWARA, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research January 2017, 37 (1) 57-60;
  • You have access
    Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel
    TAKASHI MURAKAMI, TAKUYA MURATA, KEI KAWAGUCHI, TASUKU KIYUNA, KENTARO IGARASHI, HO KYOUNG HWANG, YUKIHIKO HIROSHIMA, CHIHIRO HOZUMI, SHIN KOMATSU, TAKASHI KIKUCHI, THINZAR M. LWIN, JONATHAN C. DELONG, KENTARO MIYAKE, YONG ZHANG, KUNIYA TANAKA, MICHAEL BOUVET, ITARU ENDO and ROBERT M. HOFFMAN
    Anticancer Research January 2017, 37 (1) 61-65;
  • You have access
    A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression
    XIAOMEI YANG, GUIFANG DU, ZHEN YU, YANG SI, TRACEY A. MARTIN, JUNQI HE, SHAN CHENG and WEN G. JIANG
    Anticancer Research January 2017, 37 (1) 67-73;
  • You have access
    YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin
    TAKASHI NITTA, HIDEKAZU KOIKE, TAKESHI MIYAO, YOSHIYUKI MIYAZAWA, HARUO KATO, YOSUKE FURUYA, YOSHITAKA SEKINE and KAZUHIRO SUZUKI
    Anticancer Research January 2017, 37 (1) 75-80;
  • You have access
    Long Noncoding RNA PANDA Positively Regulates Proliferation of Osteosarcoma Cells
    YOJIRO KOTAKE, TAIKI GOTO, MADOKA NAEMURA, YASUTOSHI INOUE, HARUNA OKAMOTO and KEIICHIRO TAHARA
    Anticancer Research January 2017, 37 (1) 81-85;
  • You have access
    Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro
    NORBERT NASS, SEBASTIAN STREIT, CHRISTIAN WYBRANSKI, JULIAN JÜRGENS, JAN BRAUNER, NADINE SCHULZ, MACIEJ POWERSKI, JENS RICKE, THOMAS KALINSKI, OLIVER DUDECK and MAX SEIDENSTICKER
    Anticancer Research January 2017, 37 (1) 87-93;
  • You have access
    The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7)
    LENNARD SCHRÖDER, JULIAN KOCH, SVEN MAHNER, BERND P. KOST, SIMONE HOFMANN, UDO JESCHKE, JENS HAUMANN, JULIAN SCHMEDT and DAGMAR ULRIKE RICHTER
    Anticancer Research January 2017, 37 (1) 95-102;
  • You have access
    Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis
    MINHEE PARK, PASUPATHI SUNDARAMOORTHY, JAE JUN SIM, KEUN-YEONG JEONG and HWAN MOOK KIM
    Anticancer Research January 2017, 37 (1) 103-114;
  • You have access
    Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB
    CHARUPONG SAENGBOONMEE, WUNCHANA SEUBWAI, UBON CHA'ON, KANLAYANEE SAWANYAWISUTH, SOPIT WONGKHAM and CHAISIRI WONGKHAM
    Anticancer Research January 2017, 37 (1) 115-123;
  • You have access
    Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer
    TSOGT-OCHIR DONDOO, TOMOHARU FUKUMORI, KEI DAIZUMOTO, TOMOYA FUKAWA, MIHO KOHZUKI, MINORU KOWADA, YOSHITO KUSUHARA, HIDEHISA MORI, HIROYOSHI NAKATSUJI, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA
    Anticancer Research January 2017, 37 (1) 125-134;
  • You have access
    Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer
    DAKEUN LEE, EUN JI YU, IN-HYE HAM and HOON HUR
    Anticancer Research January 2017, 37 (1) 135-142;
  • You have access
    Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma
    SOTIRIOS P. FORTIS, ELEFTHERIA A. ANASTASOPOULOU, IOANNIS F. VOUTSAS, CONSTANTIN N. BAXEVANIS, SONIA A. PEREZ and LOUISA G. MAHAIRA
    Anticancer Research January 2017, 37 (1) 143-148;
  • You have access
    Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes
    ZHIVKO ZHELEV, DONIKA IVANOVA, RUMIANA BAKALOVA, ICHIO AOKI and TATSUYA HIGASHI
    Anticancer Research January 2017, 37 (1) 149-159;
  • You have access
    Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells
    I-TSANG CHIANG, WEI-TING CHEN, CHIH-WEI TSENG, YEN-CHUNG CHEN, YU-CHENG KUO, BI-JHIH CHEN, MAO-CHI WENG, HWAI-JENG LIN and WEI-SHU WANG
    Anticancer Research January 2017, 37 (1) 161-167;

Clinical Studies

  • You have access
    Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer
    DIMPLE CHUDASAMA, JAMES BARR, JULIE BEESON, EMMA BEDDOW, NIALL MCGONIGLE, ALEXANDRA RICE, ANDREW NICHOLSON and VLADIMIR ANIKIN
    Anticancer Research January 2017, 37 (1) 169-173;
  • You have access
    Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases
    LEENA STRIEN, KRISTIINA JOENSUU, PÄIVI HEIKKILÄ and MARJUT H. LEIDENIUS
    Anticancer Research January 2017, 37 (1) 175-182;
  • You have access
    Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
    TAKUYA MIURA, TADASHI YOSHIZAWA, HIDEAKI HIRAI, HIROKO SEINO, SATOKO MOROHASHI, YUNYAN WU, TAIICHI WAKIYA, NORIHISA KIMURA, DAISUKE KUDO, KEINOSUKE ISHIDO, YOSHIKAZU TOYOKI, HIROSHI KIJIMA and KENICHI HAKAMADA
    Anticancer Research January 2017, 37 (1) 183-190;
  • You have access
    Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis
    NORIMICHI KOGURE, TAKEHIKO YOKOBORI, KYOICHI OGATA, BOLAG ALTAN, ERITO MOCHIKI, TETSURO OHNO, YOSHITAKA TOYOMASU, MITSUHIRO YANAI, AKIHARU KIMURA, TORU YANOMA, MASAKI SUZUKI, TUYA BAI, TAKAYUKI ASAO and HIROYUKI KUWANO
    Anticancer Research January 2017, 37 (1) 191-196;
  • You have access
    Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer
    ZORAN JUKIC, PETRA RADULOVIC, RANKO STOJKOVIĆ, AUGUST MIJIC, JOSIP GRAH, BOZO KRUSLIN, ZELJKO FERENCIC and ALEKSANDRA FUCIC
    Anticancer Research January 2017, 37 (1) 197-202;
  • You have access
    Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer
    DIRK RADES, LOUISA BOLM, STEVEN E. SCHILD and TOBIAS BARTSCHT
    Anticancer Research January 2017, 37 (1) 203-206;
  • You have access
    Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
    YOHEI YURUGI, MAKOTO WAKAHARA, YUKI MATSUOKA, TOMOHIKO SAKABE, YASUAKI KUBOUCHI, TOMOHIRO HARUKI, KANAE NOSAKA, KEN MIWA, KUNIO ARAKI, YUJI TANIGUCHI, TATSUSHI SHIOMI, HIROSHIGE NAKAMURA and YOSHIHISA UMEKITA
    Anticancer Research January 2017, 37 (1) 207-213;
  • You have access
    mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer
    ULRIKE I. ATTENBERGER, MELISSA M. ONG, NILS RATHMANN, FABIAN DOYON, PETER KIENLE, RALF-DIETER HOFHEINZ, LOTHAR R. PILZ, DIETMAR J. DINTER, STEFAN O. SCHOENBERG and DANIEL HAUSMANN
    Anticancer Research January 2017, 37 (1) 215-222;
  • You have access
    Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature
    SARAH VINZENS, JOEL ZINDEL, MARTIN ZWEIFEL, TILMAN RAU, BEAT GLOOR and ANNETTE WOCHNER
    Anticancer Research January 2017, 37 (1) 223-228;
  • You have access
    Identification and Management of Head and Neck Cancer Recurrences Detected on Adjuvant Radiation Oncology Simulation Scans
    RICHARD L. BAKST and WILLIAM SU
    Anticancer Research January 2017, 37 (1) 229-232;
  • You have access
    Gemcitabine and S-1 Induction Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancers
    KOSEI MAEMURA, YUKO MATAKI, HIROSHI KURAHARA, YOTA KAWASAKI, SATOSHI IINO, MASAHIKO SAKODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, YOSHIKAZU UENOSONO, SHINICHIRO MORI, SHINICHI UENO, HIROYUKI SHINCHI and SHOJI NATSUGOE
    Anticancer Research January 2017, 37 (1) 233-237;
  • You have access
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor
    KENJI FUJIYOSHI, GOU YAMAMOTO, TAKASHI TAKENOYA, AKEMI TAKAHASHI, YOSHIKO ARAI, MINA YAMADA, MIHO KAKUTA, KENSEI YAMAGUCHI, YOSHITO AKAGI, YOJI NISHIMURA, HIROHIKO SAKAMOTO and KIWAMU AKAGI
    Anticancer Research January 2017, 37 (1) 239-247;
  • You have access
    Development of a Survival Score for Patients with Cerebral Metastases from Melanoma
    LENA SEHMISCH, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research January 2017, 37 (1) 249-252;
  • You have access
    A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib
    CLIVE STUBBS, ANTONIO D. BARDOLI, MEHRAN AFSHAR, SARAH PIRRIE, MANUELA MISCORIA, ISABELLA WHEELEY and EMILIO PORFIRI
    Anticancer Research January 2017, 37 (1) 253-259;
  • You have access
    Laparoscopic versus Open Partial Nephrectomy: Comparison of Overall and Subgroup Outcomes
    MOHAMED ABDELHAFEZ, AMEND BASTIAN, STEFFEN RAUSCH, ARNULF STENZL, JENS BEDKE and STEPHAN KRUCK
    Anticancer Research January 2017, 37 (1) 261-265;
  • You have access
    Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer
    YOSHINAGA OKUGAWA, YUMIKO SHIRAI, HIROKO NODONO, FUKUMI MATSUTANI, MARI ITOH, ASAHI HISHIDA, YUKI MORIMOTO, RYUTARO NISHIKAWA, TAKESHI YOKOE, KOJI TANAKA, HISASHI URATA, YUJI TOIYAMA, TOSHIMITSU ARAKI, YASUHIRO INOUE, MOTOYOSHI TANAKA, MASATO KUSUNOKI and CHIKAO MIKI
    Anticancer Research January 2017, 37 (1) 267-275;
  • You have access
    Surgical Resection of Giant Pheochromocytomas Arising Behind the Retrohepatic Inferior Vena Cava
    YUJI SOEJIMA, TOMOHARU YOSHIZUMI, TORU IKEGAMI, NORIFUMI HARIMOTO, SHINJI ITO, NOBORU HARADA, TAKASHI MOTOMURA, AKIHISA NAGATSU, TETSUO IKEDA and YOSHIHIKO MAEHARA
    Anticancer Research January 2017, 37 (1) 277-280;
  • You have access
    Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer
    MARISA D. SANTOS, CRISTINA SILVA, ANABELA ROCHA, CARLOS NOGUEIRA, FERNANDO CASTRO-POÇAS, ANTÓNIO ARAUJO, EDUARDA MATOS, CARINA PEREIRA, RUI MEDEIROS and CARLOS LOPES
    Anticancer Research January 2017, 37 (1) 281-291;
  • You have access
    Association of Inflammasome Components in Background Liver with Poor Prognosis After Curatively-resected Hepatocellular Carcinoma
    FUMINORI SONOHARA, YOSHIKUNI INOKAWA, MITSURO KANDA, YOKO NISHIKAWA, SUGURU YAMADA, TSUTOMU FUJII, HIROYUKI SUGIMOTO, YASUHIRO KODERA and SHUJI NOMOTO
    Anticancer Research January 2017, 37 (1) 293-300;
  • You have access
    Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies
    KEN SUZAWA, KAZUHIKO SHIEN, HUANG PENG, MASAKIYO SAKAGUCHI, MASAMI WATANABE, SHINSUKE HASHIDA, YUHO MAKI, HIROMASA YAMAMOTO, SHUTA TOMIDA, JUNICHI SOH, HIROAKI ASANO, KAZUNORI TSUKUDA, YASUTOMO NASU, HIROMI KUMON, SHINICHIRO MIYOSHI and SHINICHI TOYOOKA
    Anticancer Research January 2017, 37 (1) 301-307;
  • You have access
    Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular Coagulation
    KEIJI SUGIYAMA, YUKIYA NARITA, SHIGENORI KADOWAKI, TAKASHI URA, MASAHIRO TAJIKA and KEI MURO
    Anticancer Research January 2017, 37 (1) 309-313;
  • You have access
    Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer
    FRANCESCO PASQUALETTI, SABRINA MONTRONE, CATERINA VIVALDI, MARGHERITA ZANI, DAVID FEDELE, LORENZO FORNARO, GIUSEPPE PASQUALETTI, LISA SALVATORE, BRUNO MANFREDI, CONCETTA LALISCIA, GABRIELE CORAGGIO, ALESSANDRA GONNELLI, FOTIOS LOUPAKIS, GIANLUCA MASI, ALDO SAINATO, FABIO MONZANI, ALFREDO FALCONE and FABIOLA PAIAR
    Anticancer Research January 2017, 37 (1) 315-319;
  • You have access
    Technical Feasibility and Oncological Legitimacy of Enucleation of Intraductal Papillary Mucinous Neoplasm Located at the Pancreatic Head or Uncinate Process
    YUJI SOEJIMA, TAKEO TOSHIMA, TAKASHI MOTOMURA, TOMOYUKI YOKOTA, KOUJI JOKO, YUMI OSHIRO, IKUO TAKAHASHI, TAKASHI NISHIZAKI and YOSHIHIKO MAEHARA
    Anticancer Research January 2017, 37 (1) 321-326;
  • You have access
    Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer
    OYEON CHO, O KYU NOH, YOUNG-TAEK OH, SUK-JOON CHANG and MISON CHUN
    Anticancer Research January 2017, 37 (1) 327-334;
  • You have access
    Minimally Invasive Lymphadenectomy in Uterine Cervical Cancer: A Systematic Review
    NATASA RIZOU, DEMETRIOS MORIS, EMMANOUIL PIKOULIS, NIKOLAOS DIMITROKALLIS, EUSTRATIA MPAILI, EVANGELOS FELEKOURAS and ALEXANDROS PAPALAMPROS
    Anticancer Research January 2017, 37 (1) 335-342;
  • You have access
    Double Endoscopic Intraluminal Operation (DEILO) for Early Gastric Cancer: Outcome of Novel Procedure for Endoscopic Submucosal Dissection
    KYOICHI OGATA, MITSUHIRO YANAI, KENGO KURIYAMA, MASAKI SUZUKI, TORU YANOMA, AKIHARU KIMURA, NORIMICHI KOGURE, YOSHITAKA TOYOMASU, TETSURO OHNO, ERITO MOCHIKI and HIROYUKI KUWANO
    Anticancer Research January 2017, 37 (1) 343-347;
  • You have access
    Tumescent Anesthesia in Skin- and Nipple-sparing Mastectomy: Results of a Prospective Clinical Study
    MARCO GIPPONI, ILARIA BALDELLI, GIULIA ATZORI, PIERO FREGATTI, FEDERICA MURELLI, MARIANNA PESCE, CECILIA MARGARINO, FRANCESCA DEPAOLI and DANIELE FRIEDMAN
    Anticancer Research January 2017, 37 (1) 349-352;
  • You have access
    Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays
    RAMONA C. DOLSCHEID-POMMERICH, STEFFEN MANEKELLER, GISELA WALGENBACH-BRÜNAGEL, JÖRG C. KALFF, GUNTHER HARTMANN, BIRGIT STOFFEL WAGNER and STEFAN HOLDENRIEDER
    Anticancer Research January 2017, 37 (1) 353-359;

BOOK REVIEWS

  • You have access
    Book Reviews
    Anticancer Research January 2017, 37 (1) 361;
  • You have access
    Thyroid Cancer. A Comprehensive Guide to Clinical Management. Third Edition
    Anticancer Research January 2017, 37 (1) 361;
  • You have access
    Hepatocellular Carcinoma. Diagnosis and Treatment. Third Edition
    Anticancer Research January 2017, 37 (1) 361;
  • You have access
    Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. General and Surgical Pathology. Volumes 1, 2, 3, 4
    Anticancer Research January 2017, 37 (1) 361;
  • You have access
    DNA Repair in Cancer Therapy, 2nd Edition. Molecular Targets and Clinical Applications
    Anticancer Research January 2017, 37 (1) 362;
  • You have access
    The Functional Nucleus
    Anticancer Research January 2017, 37 (1) 362;
  • You have access
    Enhancer RNAs. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 362;
  • You have access
    RNA Structure Determination. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 362;
  • You have access
    Pathology and Epidemiology of Cancer
    Anticancer Research January 2017, 37 (1) 362-363;
  • You have access
    Cancer Stem Cells, 1st Edition. Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
    Anticancer Research January 2017, 37 (1) 363;
  • You have access
    Stem Cell Heterogeneity. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 363;
  • You have access
    Stem Cell Processing
    Anticancer Research January 2017, 37 (1) 363;
  • You have access
    Working with Stem Cells
    Anticancer Research January 2017, 37 (1) 363;
  • You have access
    Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract
    Anticancer Research January 2017, 37 (1) 363-364;
  • You have access
    The Nucleolus. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 364;
  • You have access
    The Wilms' Tumor (WT1) Gene. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 364;
  • You have access
    Synthetic DNA. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 364;
  • You have access
    The Tumor Microenvironment. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 364-365;
  • You have access
    Pathology of Transplantation. A Practical Diagnostic Approach
    Anticancer Research January 2017, 37 (1) 365;
  • You have access
    The Pathobiology of Breast Cancer
    Anticancer Research January 2017, 37 (1) 365;
  • You have access
    Metabolism in Cancer
    Anticancer Research January 2017, 37 (1) 365;
  • You have access
    Protein Tyrosine Phosphatases in Cancer
    Anticancer Research January 2017, 37 (1) 365;
  • You have access
    Cancer Biomarkers in Body Fluids. Biomarkers in Circulation
    Anticancer Research January 2017, 37 (1) 365-366;
  • You have access
    Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances
    Anticancer Research January 2017, 37 (1) 366;
  • You have access
    Hepatitis C Virus I. Cellular and Molecular Virology
    Anticancer Research January 2017, 37 (1) 366;
  • You have access
    Epigenetics, Energy Balance, and Cancer
    Anticancer Research January 2017, 37 (1) 366;
  • You have access
    Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, 1st Edition. Volume 10
    Anticancer Research January 2017, 37 (1) 366-367;
  • You have access
    Nanotechnology in Cancer, 1st Edition
    Anticancer Research January 2017, 37 (1) 367;
  • You have access
    Molecular and Cellular Basis of Metastasis: Road to Therapy, Volume 132. 1st Edition
    Anticancer Research January 2017, 37 (1) 367;
  • You have access
    Systems Biology of Tumor Microenvironment. Quantitative Modeling and Simulations
    Anticancer Research January 2017, 37 (1) 367;
  • You have access
    Perspectives on Fluorescence. A Tribute to Gregorio Weber
    Anticancer Research January 2017, 37 (1) 367;
  • You have access
    Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy
    Anticancer Research January 2017, 37 (1) 367-368;
  • You have access
    Colon, Rectum and Anus: Anatomic, Physiologic and Diagnostic Bases for Disease Management
    Anticancer Research January 2017, 37 (1) 368;
  • You have access
    T-Cell Differentiation. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 368;
  • You have access
    Germline Stem Cells
    Anticancer Research January 2017, 37 (1) 368;
  • You have access
    Chronic Myeloid Leukemia. Methods and Protocols
    Anticancer Research January 2017, 37 (1) 368;
  • You have access
    Chronic Myeloid Leukemia
    Anticancer Research January 2017, 37 (1) 368-369;
  • You have access
    Non-coding RNAs in Colorectal Cancer
    Anticancer Research January 2017, 37 (1) 369;
  • You have access
    Skin Care in Radiation Oncology. A Practical Guide
    Anticancer Research January 2017, 37 (1) 369;
  • You have access
    Radiation Therapy in Hematologic Malignancies. An Illustrated Practical Guide
    Anticancer Research January 2017, 37 (1) 369;
  • You have access
    Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
    Anticancer Research January 2017, 37 (1) 369;
  • You have access
    Radiation Therapy Techniques and Treatment Planning for Breast Cancer
    Anticancer Research January 2017, 37 (1) 369-370;
  • You have access
    Conquering RAS, 1st Edition. From Biology to Cancer Therapy
    Anticancer Research January 2017, 37 (1) 370;
  • You have access
    Modified Nucleic Acids in Biology and Medicine
    Anticancer Research January 2017, 37 (1) 370;
  • You have access
    Targeting Autophagy in Cancer Therapy
    Anticancer Research January 2017, 37 (1) 370;
  • You have access
    STAT Inhibitors in Cancer
    Anticancer Research January 2017, 37 (1) 370;
  • You have access
    Microtechnology for Cell Manipulation and Sorting
    Anticancer Research January 2017, 37 (1) 371;
  • You have access
    Circulating Nucleic Acids in Serum and Plasma – CNAPS IX
    Anticancer Research January 2017, 37 (1) 371;
  • You have access
    Polymeric Biomaterials for Tissue Regeneration
    Anticancer Research January 2017, 37 (1) 371;
  • You have access
    Translating Molecular Biomarkers into Clinical Assays. Techniques and Applications
    Anticancer Research January 2017, 37 (1) 371;
  • You have access
    Apoptosis in Cancer Pathogenesis and Anti-cancer Therapy. New Perspectives and Opportunities
    Anticancer Research January 2017, 37 (1) 371;
  • You have access
    Cancer of the Oral Cavity, Pharynx and Larynx. Evidence-Based Decision Making
    Anticancer Research January 2017, 37 (1) 372;
  • You have access
    Material Parameter Identification and Inverse Problems in Soft Tissue Biomechanics
    Anticancer Research January 2017, 37 (1) 372;
  • You have access
    Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges
    Anticancer Research January 2017, 37 (1) 372;
  • You have access
    Early Nutrition and Lifestyle Factors. Effects on First Trimester Placenta
    Anticancer Research January 2017, 37 (1) 372-373;
  • You have access
    Chemistry of the Mediterranean Diet
    Anticancer Research January 2017, 37 (1) 373;
  • You have access
    Philosophy of Cancer. A Dynamic and Relational View
    Anticancer Research January 2017, 37 (1) 373;
  • You have access
    Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology
    Anticancer Research January 2017, 37 (1) 373;
  • You have access
    Handbook of Lymphoma
    Anticancer Research January 2017, 37 (1) 374;
  • You have access
    Drug Therapy and Interactions in Pediatric Oncology. A Pocket Guide
    Anticancer Research January 2017, 37 (1) 374;
  • You have access
    Molecular Cytopathology
    Anticancer Research January 2017, 37 (1) 374;

Announcements

  • You have access
    Announcements
    Anticancer Research January 2017, 37 (1) 375;
Back to top
PreviousNext

In this issue

Anticancer Research: 37 (1)
Anticancer Research
Vol. 37, Issue 1
January 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • BOOK REVIEWS
  • Announcements
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire